Through machine learning techniques, this study further identified biomarkers (C5orf58, CTAG1A, ZNF180, and IL13RA1) that are closely associated with CHD pathology, suggesting their potential as therapeutic targets. Here, IL13RA1 is linked to coronary artery disorder.